 Codexis Inc NASDAQ: CDXS expects Q2 sales of approximately 38 million and FY22 sales of 135 million to 141 million, below the propr expectation of 152 million - 158 million. FY22 product revenues are expected to be 112 million - 118 million, consistent with prior. 